Lemonade is a monster stock in the making after a massive quarter. Per co-founder @shai_wininger, in-force premium grew 32% to $1.33 billion, the 10th straight quarter of acceleration, revenue rose 71% to $258M and gross profit 159% to $100M, with $17M of adjusted free cash flow. Pet passed $500M of premium, car grew 60% with its loss ratio down 14 points to 74%, and Lemonade raised 2026 guidance, targeting positive adjusted EBITDA in Q4. x.com 

Lemonade is one of the best buys in the market because its AI model lets it scale customers, products and revenue without scaling headcount. In-force premium grew 32% YoY, its tenth straight quarter of acceleration, and doubled over three years as headcount fell; revenue tripled while gross profit grew 10x. Up to 50% discounts for miles driven on Tesla FSD show an edge traditional insurers can't copy. It should be EBITDA profitable in Q4 2026, yet the stock fell 50% in four months. x.com  x.com 

Lemonade looks expensive once valued as what it is, an insurance company. Replying to @javierluraschi's post on the stock, any price above 1x revenue is expensive for an insurer. x.com 

Root looks cheap at about 7x earnings while buying back shares, with proven fully loaded economics. Even after $25.3 million of sales and marketing and $32 million of partner acquisition costs, it earned $25 million of GAAP profit with a 92.1% combined ratio. Lemonade grows much faster and may have more upside if retention and cross-sell deliver, but its case rests on modeled lifetime value and its shareholders keep getting diluted. Root's premium volume is roughly flat to down. x.com  x.com  … Show more

Lemonade's business thesis has not broken; the stock is falling on normal high-beta behavior, not fundamentals. With beta over two, high short interest and no profits yet, it moves sharply with risk appetite. Co-founder Daniel Schreiber's share sales are normal for a founder with concentrated wealth, though their framing was tone deaf, and stock pay is needed to hire engineers against Google and Meta. Long-term holders should watch in-force premium growth, loss ratio and operating leverage. … Show more

Lemonade looks good but not good enough after a lofty price and high expectations into earnings, so it needs to get cheaper before it is worth buying. In-force premium grew 32% and revenue 79% as it approaches positive cash flow by the end of 2026; the low $40s or $30s would be the level to buy more. x.com  x.com 

Lemonade is light years ahead of competitors in agentic insurance as policies shift from set-and-forget to hundreds of micro-interactions each year. It is the first company to truly enter this model while incumbents still work on AI premium-pricing models. Pet insurance involves frequent small claims, and car telematics keeps updating driving-based prices and safety assessments. x.com 

Lemonade's approach to building an AI-agent insurance platform could become the global standard. Building a complete way for agents to buy, renew or file claims through Lemonade OS is brilliant; the company is building for the agentic era. x.com 

Lemonade is reducing transparency on a key indicator of whether it can scale efficiently. Earnings reports once showed in-force premium versus opex, then switched to premium versus employee count, presumably as opex rose, and now show premium alone. Investors are tiring of waiting for EBITDA profitability, and the missing comparative metrics give less insight into how Lemonade gets there. The stock had run ahead into earnings, so a reset was due without a blowout. x.com  x.com 

Lemonade could justify a $30-40B valuation by 2030 if it pairs growth with AI-driven margins, though this is a framework, not a price target. Compounding in-force premium 35-40% a year, led by Car and multi-product customers, could reach about $6B and $5.25B revenue; at a 20% EBITDA margin, 6-8x sales means $31.5-42B. In Q2 premium grew 33% and revenue 79% while headcount rose only about 5%. It must still control loss ratios and turn EBITDA consistently positive. x.com